Neuroscience News and Research

RSS

New gene required for memory formation identified

A team led by a Scripps Research Institute scientist has for the first time identified a new gene that is required for memory formation in Drosophila, the common fruit fly. The gene may have similar functions in humans, shedding light on neurological disorders such as Alzheimer's disease or human learning disabilities.

9 Sep 2010

UCLA psychologist explains measure to overcome drug addiction

Millions of Americans suffer from severe addictions that can ruin lives and are extremely difficult to control. Nearly 2 million enter roughly 12,000 addiction treatment programs in the U.S. each year.

9 Sep 2010

Scientists discover natural mechanism to discard amyloid protein

Chemists at the University of California, San Diego, have identified how a protein that accumulates in the brains of people with Alzheimer's disease interferes with the ability of cells to get rid of debris. They also found a natural mechanism by which this protein, amyloid beta, itself may be discarded.

9 Sep 2010

ECNP honors Kaj Blennow with 2010 Neuropsychopharmacology Award

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of - 20,000.

8 Sep 2010

Abbott completes acquisition of Piramal's Healthcare Solutions

Abbott has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets.

8 Sep 2010

Study shows mild cognitive impairment affects men more than women

A new study shows that mild cognitive impairment (MCI) may affect more men than women. The research is published in the September 7, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

7 Sep 2010

Kavli Day 2010 at Norwegian University of Science and Technology

In celebration of Kavli Prize Week, the Norwegian University of Science and Technology (NTNU), the Norwegian Academy of Science and Letters, and the Kavli Foundation will hold a series of lectures and events on 9 September 2010 in Trondheim, Norway at the NTNU campus. The event features a number of 2010 Kavli Prize Laureates. The festivities continue after the official celebration, with two symposia sponsored by NTNU, one in neuroscience and one in nanoscience.

4 Sep 2010

Research findings help understand effect of cognitive functions in people with Parkinson's disease

Researchers at Queen's University have found that people with Parkinson's disease can perform automated tasks better than people without the disease, but have significant difficulty switching from easy to hard tasks. The findings are a step towards understanding the aspects of the illness that affect the brain's ability to function on a cognitive level.

4 Sep 2010

Maryland Stem Cell Research Commission partners with NIH, NIST to host symposium on stem cell research

The Maryland Stem Cell Research Commission will host the Third Annual Maryland Stem Cell Research Symposium in partnership with the National Institutes of Health and the National Institute of Standards and Technology on Wednesday, Sept. 22, 2010.

4 Sep 2010

TNS therapy improves depression: Study

Major depression is a common and disabling brain condition marked not only by the presence of depressed mood but also by its effects on sleep, energy, decision-making, memory and thoughts of death or of suicide.

3 Sep 2010

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

MSD announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The Commission Decision applies to all 27 European Member States.

3 Sep 2010

Benefit of delaying cognitive decline comes at the cost of more rapid dementia progression

New research shows that mentally stimulating activities such as crossword puzzles, reading and listening to the radio may, at first, slow the decline of thinking skills but speed up dementia later in old age. The research is published in the September 1, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Sep 2010

Evotec AG announces Closing conditions to acquire DeveloGen

Evotec AG today announced the Closing of the agreement to acquire DeveloGen as announced in detail on 14 July 2010.

2 Sep 2010

Pfizer enters agreement to acquire FoldRx Pharmaceuticals

Pfizer Inc. and FoldRx Pharmaceuticals, Inc., a privately held drug discovery and clinical development company, today announced that they have entered into an agreement under which Pfizer will acquire FoldRx.

2 Sep 2010

Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.

2 Sep 2010

TBSI Neuroscience Symposium to discuss traumatic brain injury

Brazos Valley residents, neuroscience researchers, and interested clinicians will each have opportunities to hear from nationally recognized clinicians and researchers on the topic of Traumatic Brain Injury during the Texas Brain and Spine Institute's Fourth Annual Neuroscience Symposium on September 10, 2010.

2 Sep 2010

UTHealth professor to receive NIH Director's Pioneer Award

Valentin Dragoi, Ph.D., an associate professor of neurobiology and anatomy at The University of Texas Health Science Center at Houston (UTHealth), is one of 17 researchers to win a 2010 National Institutes of Health Director's Pioneer Award. The award supports scientists who propose revolutionary, high-impact approaches to major challenges in biomedical and behavioral research.

2 Sep 2010

Naurex announces GLYX-13 molecule recognized in “Top 10 to Watch" list for depression treatment

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."

31 Aug 2010

Social interaction reduces physical damage to brain by heart attack: Research

A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.

31 Aug 2010

Brain lesion scan appearance shows increased multiple sclerosis activity during spring and summer

New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

31 Aug 2010